fluocinolone acetonide

(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one

FEBLZLNTKCEFIT-VSXGLTOVSA-N CHEBI:31623 8 Reactome links 4 studies

4 Observed studies

4 Observed diff profiles

8 Reactome pathways

Metabolite details

Identifier: FEBLZLNTKCEFIT-VSXGLTOVSA-N
InChI Key: FEBLZLNTKCEFIT-VSXGLTOVSA-N
IUPAC name: (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
Preferred name: fluocinolone acetonide
INN name: acétonide de fluocinolone
Synonym: 6α-fluorotriamcinolone acetonide
ChEBI: CHEBI:31623

Reactome pathways

R-HSA-1643685 - Disease
R-HSA-2262752 - Cellular responses to stress
R-HSA-3371497 - HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
R-HSA-5663205 - Infectious disease
R-HSA-8953897 - Cellular responses to stimuli
R-HSA-9679191 - Potential therapeutics for SARS
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9824446 - Viral Infection Pathways

Observed in studies

Observed in differential profiles